Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38B Buy
11,446,845
+398,634
+4% +$46M 0.26% 83
2025
Q4
$1.16B Buy
11,048,211
+599,651
+6% +$56.3M 0.21% 100
2025
Q3
$877M Sell
10,448,560
-934,528
-8% -$77M 0.17% 119
2025
Q2
$901M Sell
11,383,088
-516,064
-4% -$41M 0.19% 113
2025
Q1
$1.07B Sell
11,899,152
-2,966,636
-20% -$277M 0.24% 91
2024
Q4
$1.48B Sell
14,865,788
-52,033
-0.3% -$5.36M 0.33% 70
2024
Q3
$1.69B Sell
14,917,821
-700,139
-4% -$83.2M 0.38% 62
2024
Q2
$1.93B Sell
15,617,960
-758,740
-5% -$97.7M 0.47% 48
2024
Q1
$2.16B Buy
16,376,700
+114,181
+0.7% +$14.1M 0.52% 43
2023
Q4
$1.77B Sell
16,262,519
-151,738
-0.9% -$15.8M 0.46% 52
2023
Q3
$1.69B Sell
16,414,257
-1,185,625
-7% -$128M 0.5% 44
2023
Q2
$2.03B Sell
17,599,882
-271,419
-2% -$30.8M 0.56% 34
2023
Q1
$1.9B Sell
17,871,301
-453,650
-2% -$49M 0.55% 33
2022
Q4
$2.03B Sell
18,324,951
-572,173
-3% -$58.5M 0.61% 30
2022
Q3
$1.63B Sell
18,897,124
-206,536
-1% -$18.4M 0.53% 37
2022
Q2
$1.74B Sell
19,103,660
-928,242
-5% -$82.3M 0.54% 34
2022
Q1
$1.64B Buy
20,031,902
+1,354,007
+7% +$107M 0.42% 47
2021
Q4
$1.43B Sell
18,677,895
-2,212,150
-11% -$176M 0.36% 59
2021
Q3
$1.57B Sell
20,890,045
-499,610
-2% -$38M 0.34% 49
2021
Q2
$1.66B Sell
21,389,655
-2,030,358
-9% -$151M 0.36% 48
2021
Q1
$1.72B Sell
23,420,013
-68,826
-0.3% -$5.08M 0.39% 43
2020
Q4
$1.83B Sell
23,488,839
-505,761
-2% -$38.7M 0.44% 37
2020
Q3
$1.9B Sell
23,994,600
-679,027
-3% -$53.2M 0.52% 31
2020
Q2
$1.82B Buy
24,673,627
+587,684
+2% +$44.2M 0.53% 28
2020
Q1
$1.77B Sell
24,085,943
-105,888
-0.4% -$8.32M 0.61% 27
2019
Q4
$2.1B Sell
24,191,831
-887,580
-4% -$72.9M 0.57% 22
2019
Q3
$2.01B Buy
25,079,411
+1,096,376
+5% +$87.9M 0.57% 22
2019
Q2
$1.92B Sell
23,983,035
-1,090,761
-4% -$83.5M 0.55% 22
2019
Q1
$1.99B Sell
25,073,796
-826,001
-3% -$61.8M 0.59% 21
2018
Q4
$1.89B Buy
25,899,797
+1,273,385
+5% +$89.9M 0.63% 20
2018
Q3
$1.67B Sell
24,626,412
-1,601,867
-6% -$102M 0.47% 28
2018
Q2
$1.52B Sell
26,228,279
-2,935,359
-10% -$166M 0.45% 28
2018
Q1
$1.52B Buy
29,163,638
+3,532,252
+14% +$191M 0.45% 30
2017
Q4
$1.38B Buy
25,631,386
+650,895
+3% +$36.1M 0.4% 42
2017
Q3
$1.53B Buy
24,980,491
+790,929
+3% +$48M 0.47% 28
2017
Q2
$1.48B Sell
24,189,562
-1,379,398
-5% -$84M 0.47% 29
2017
Q1
$1.55B Buy
25,568,960
+3,601,311
+16% +$218M 0.5% 26
2016
Q4
$1.23B Buy
21,967,649
+1,257,818
+6% +$73.6M 0.44% 35
2016
Q3
$1.23B Buy
20,709,831
+1,128,112
+6% +$66M 0.45% 35
2016
Q2
$1.08B Buy
19,581,719
+384,230
+2% +$20.4M 0.42% 39
2016
Q1
$969M Buy
19,197,489
+368,392
+2% +$18M 0.39% 45
2015
Q4
$949M Buy
18,829,097
+895,793
+5% +$45.2M 0.37% 46
2015
Q3
$845M Buy
17,933,304
+2,882,532
+19% +$153M 0.35% 50
2015
Q2
$818M Buy
15,050,772
+72,070
+0.5% +$4.04M 0.32% 56
2015
Q1
$822M Buy
14,978,702
+1,336,236
+10% +$75.7M 0.32% 54
2014
Q4
$739M Buy
13,642,466
+990,072
+8% +$55.2M 0.29% 67
2014
Q3
$716M Buy
12,652,394
+607,504
+5% +$34.1M 0.3% 60
2014
Q2
$665M Sell
12,044,890
-477,547
-4% -$26.1M 0.27% 66
2014
Q1
$678M Buy
12,522,437
+768,632
+7% +$39.8M 0.29% 68
2013
Q4
$561M Buy
11,753,805
+725,693
+7% +$33.2M 0.24% 90
2013
Q3
$501M Buy
11,028,112
+3,847
+0% +$176K 0.24% 89
2013
Q2
$489M Buy
+11,024,265
New +$492M 0.25% 85

Other funds holding MRK

Wells Fargo's MRK Position: Q1 2026 in Review

Wells Fargo increased its Merck (MRK) stake by 3.6% in Q1 2026, buying an estimated $46M and bringing the position to 11,446,845 shares worth $1.38B. The position accounts for 0.26% of the portfolio, ranked #83.

Wells Fargo first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.16B in Q1 2024. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wells Fargo held 11,446,845 shares of Merck worth $1.38B as of Q1 2026.
  • Wells Fargo bought 398,634 Merck shares in Q1 2026, an estimated $46M.
  • Merck made up 0.26% of Wells Fargo's portfolio in Q1 2026, its #83 holding.
  • Wells Fargo first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Merck position peaked at $2.16B in Q1 2024.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.